(SQM) Sociedad Quimica y Minera - Overview

Sector: Basic Materials | Industry: Specialty Chemicals | Exchange: NYSE (USA) | Market Cap: 23.622m USD | Total Return: 109.2% in 12m

Stock Fertilizers, Iodine, Lithium, Industrial Chemicals
Total Rating 61
Risk 40
Buy Signal 0.66
Specialty Chemicals +12.7
Fertilizers & Agricultural Chemicals +9.1
Market Cap: 23,622m
Avg Trading Vol: 73.0M USD
ATR: 4.66%
Peers RS (IBD): 95.8
Risk 5d forecast
Volatility47.1%
Rel. Tail Risk-4.91%
Reward TTM
Sharpe Ratio1.56
Alpha83.53
Character TTM
Beta0.949
Beta Downside0.852
Drawdowns 3y
Max DD61.84%
CAGR/Max DD0.07
EPS (Earnings per Share) EPS (Earnings per Share) of SQM over the last years for every Quarter: "2021-03": 0.26, "2021-06": 0.31, "2021-09": 0.37, "2021-12": 1.13, "2022-03": 2.79, "2022-06": 3.01, "2022-09": 3.85, "2022-12": 4.03, "2023-03": 2.63, "2023-06": 2.03, "2023-09": 1.68, "2023-12": 0.71, "2024-03": -3.04, "2024-06": -3.1, "2024-09": 0.46, "2024-12": 0.42, "2025-03": 0.48, "2025-06": 0.31, "2025-09": 0.6246, "2025-12": 0.64,
EPS CAGR: -32.47%
EPS Trend: -54.7%
Last SUE: -0.08
Qual. Beats: 0
Revenue Revenue of SQM over the last years for every Quarter: 2021-03: 528.477, 2021-06: 587.995, 2021-09: 661.551, 2021-12: 1084.292, 2022-03: 2019.818, 2022-06: 2598.812, 2022-09: 2958.348, 2022-12: 3133.599, 2023-03: 2263.85, 2023-06: 2051.741, 2023-09: 1840.26, 2023-12: 1311.639, 2024-03: 1084.517, 2024-06: 1293.617, 2024-09: 1076.869, 2024-12: 1073.757, 2025-03: 1036.63, 2025-06: 1042.677, 2025-09: 1173.047, 2025-12: 1335.694603,
Rev. CAGR: -10.44%
Rev. Trend: -84.1%
Last SUE: 0.58
Qual. Beats: 0
Risks
Technicals: volatile
Description: SQM Sociedad Quimica y Minera

Sociedad Química y Minera de Chile S.A. (SQM) is a Chilean company producing and selling specialty plant nutrients, iodine, and lithium products globally. The companys business model centers on extracting and processing natural resources to create high-value chemical compounds.

SQMs specialty plant nutrient segment includes various fertilizers sold under brands like Ultrasol and Qrop, catering to diverse agricultural needs. The iodine and derivatives segment serves medical, agricultural, and industrial applications, including X-ray contrast media and LCD screens. Iodine is a critical component in many advanced technological products.

The company is a significant producer of lithium carbonate and lithium hydroxide, essential for electric vehicle batteries and other industrial uses. The global demand for lithium is rapidly increasing due to the growth of the electric vehicle market. Additionally, SQM produces potassium sulfate and potassium chloride for crop nourishment and various industrial chemicals such as sodium nitrate and solar salts. SQM also engages in the exploration of copper, gold, and silver deposits.

For further detailed analysis of SQMs financial performance and market position, consider exploring its profile on ValueRay.

Headlines to Watch Out For
  • Lithium demand surge boosts revenue from EV battery production
  • Global fertilizer prices impact nutrient segment profitability
  • Iodine market stability supports specialty chemical sales
  • Chilean mining regulations pose operational and cost risks
  • Exchange rate fluctuations affect international sales and costs
Piotroski VR‑10 (Strict) 6.0
Net Income: 589.8m TTM > 0 and > 6% of Revenue
FCF/TA: 0.03 > 0.02 and ΔFCF/TA 0.39 > 1.0
NWC/Revenue: 87.50% < 20% (prev 74.18%; Δ 13.32% < -1%)
CFO/TA 0.09 > 3% & CFO 1.32b > Net Income 589.8m
Net Debt (3.07b) to EBITDA (1.27b): 2.41 < 3
Current Ratio: 3.27 > 1.5 & < 3
Outstanding Shares: last quarter (285.6m) vs 12m ago -0.11% < -2%
Gross Margin: 29.63% > 18% (prev 0.29%; Δ 2.93k% > 0.5%)
Asset Turnover: 35.28% > 50% (prev 39.40%; Δ -4.12% > 0%)
Interest Coverage Ratio: 6.38 > 6 (EBITDA TTM 1.27b / Interest Expense TTM 180.8m)
Altman Z'' 4.24
A: 0.28 (Total Current Assets 5.78b - Total Current Liabilities 1.77b) / Total Assets 14.52b
B: 0.28 (Retained Earnings 4.04b / Total Assets 14.52b)
C: 0.09 (EBIT TTM 1.15b / Avg Total Assets 13.01b)
D: 0.88 (Book Value of Equity 5.70b / Total Liabilities 6.46b)
Altman-Z'' Score: 4.24 = AA
Beneish M -1.51
DSRI: 1.91 (Receivables 1.14b/589.3m, Revenue 4.59b/4.53b)
GMI: 0.99 (GM 29.63% / 29.30%)
AQI: 2.39 (AQ_t 0.26 / AQ_t-1 0.11)
SGI: 1.01 (Revenue 4.59b / 4.53b)
TATA: -0.05 (NI 589.8m - CFO 1.32b) / TA 14.52b)
Beneish M-Score: -1.51 (Cap -4..+1) = CCC
What is the price of SQM shares? As of April 03, 2026, the stock is trading at USD 80.94 with a total of 2,129,696 shares traded.
Over the past week, the price has changed by +7.55%, over one month by +10.02%, over three months by +19.33% and over the past year by +109.23%.
Is SQM a buy, sell or hold? Sociedad Quimica y Minera has received a consensus analysts rating of 3.94. Therefore, it is recommended to buy SQM.
  • StrongBuy: 6
  • Buy: 4
  • Hold: 5
  • Sell: 1
  • StrongSell: 0
What are the forecasts/targets for the SQM price?
Wallstreet Target Price 74.9 -7.4%
Analysts Target Price 74.9 -7.4%
SQM Fundamental Data Overview as of 31 March 2026
P/E Trailing = 40.1456
P/E Forward = 13.986
P/S = 5.162
P/B = 3.5714
P/EG = 0.4555
Revenue TTM = 4.59b USD
EBIT TTM = 1.15b USD
EBITDA TTM = 1.27b USD
Long Term Debt = 4.22b USD (from longTermDebt, last quarter)
Short Term Debt = 493.3m USD (from shortTermDebt, last quarter)
Debt = 4.82b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.07b USD (from netDebt column, last quarter)
Enterprise Value = 25.71b USD (23.62b + Debt 4.82b - CCE 2.73b)
Interest Coverage Ratio = 6.38 (Ebit TTM 1.15b / Interest Expense TTM 180.8m)
EV/FCF = 58.75x (Enterprise Value 25.71b / FCF TTM 437.6m)
FCF Yield = 1.70% (FCF TTM 437.6m / Enterprise Value 25.71b)
FCF Margin = 9.54% (FCF TTM 437.6m / Revenue TTM 4.59b)
Net Margin = 12.85% (Net Income TTM 589.8m / Revenue TTM 4.59b)
Gross Margin = 29.63% ((Revenue TTM 4.59b - Cost of Revenue TTM 3.23b) / Revenue TTM)
Gross Margin QoQ = 34.10% (prev 29.48%)
Tobins Q-Ratio = 1.77 (Enterprise Value 25.71b / Total Assets 14.52b)
Interest Expense / Debt = 0.96% (Interest Expense 46.2m / Debt 4.82b)
Taxrate = 30.77% (104.5m / 339.4m)
NOPAT = 797.9m (EBIT 1.15b * (1 - 30.77%))
Current Ratio = 3.27 (Total Current Assets 5.78b / Total Current Liabilities 1.77b)
Debt / Equity = 0.85 (Debt 4.82b / totalStockholderEquity, last quarter 5.70b)
Debt / EBITDA = 2.41 (Net Debt 3.07b / EBITDA 1.27b)
Debt / FCF = 7.01 (Net Debt 3.07b / FCF TTM 437.6m)
Total Stockholder Equity = 5.45b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.53% (Net Income 589.8m / Total Assets 14.52b)
RoE = 10.82% (Net Income TTM 589.8m / Total Stockholder Equity 5.45b)
RoCE = 11.92% (EBIT 1.15b / Capital Employed (Equity 5.45b + L.T.Debt 4.22b))
RoIC = 7.90% (NOPAT 797.9m / Invested Capital 10.09b)
WACC = 7.85% (E(23.62b)/V(28.44b) * Re(9.32%) + D(4.82b)/V(28.44b) * Rd(0.96%) * (1-Tc(0.31)))
Discount Rate = 9.32% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF] Terminal Value 71.37% ; FCFF base≈383.1m ; Y1≈251.5m ; Y5≈115.0m
 [DCF] Fair Price = N/A (negative equity: EV 2.34b - Net Debt 3.07b = -723.8m; debt exceeds intrinsic value)
 EPS Correlation: -54.73 | EPS CAGR: -32.47% | SUE: -0.08 | # QB: 0
Revenue Correlation: -84.08 | Revenue CAGR: -10.44% | SUE: 0.58 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.74 | Chg7d=+0.065 | Chg30d=+0.680 | Revisions Net=+1 | Analysts=2
EPS current Year (2026-12-31): EPS=5.13 | Chg7d=+0.368 | Chg30d=+1.109 | Revisions Net=+3 | Growth EPS=+148.9% | Growth Revenue=+47.3%
EPS next Year (2027-12-31): EPS=5.52 | Chg7d=+0.086 | Chg30d=+0.777 | Revisions Net=+1 | Growth EPS=+7.7% | Growth Revenue=+3.9%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.8% (Discount Rate 9.3% - Earnings Yield 2.5%)
[Growth] Growth Spread = +42.0% (Analyst 48.9% - Implied 6.8%)
External Resources
Dataroma Stockcircle